# Who does Abbott Laboratories pay? Who are its key suppliers?
Canonical: https://valuechain.wiki/abbott-laboratories · Facet: suppliers · Updated: 2026-09-11T14:42:30.276155+00:00 · Source: ValueChain.wiki (cited money-flow graph)

**Citable summary**: Abbott Laboratories's confirmed suppliers/cost counterparties include Illumina, Amazon. Per the valuechain.wiki graph: 2 cost edges, backed by 3 dated sources, 2 of them primary filings (as of 2026-09-11).

### 이그젝트 사이언시스 (high)
- metric: Amount $20.6B · 2026 acquisition · Actual purchase price for Exact Sciences
- note: Abbott acquired Exact Sciences in March 2026, adding cancer screening and precision oncology to its diagnostics business. The actual purchase price reported in the second-quarter 2026 Form 10-Q was approximately $20.6 billion.
- [confirms] SEC EDGAR (EN, filing, published 2026-07-28) https://www.sec.gov/Archives/edgar/data/1800/000162828026050134/abt-20260630.htm: "Abbott completed the acquisition of Exact Sciences for approximately $20.6 billion."
- [confirms] SEC EDGAR (EN, filing, published 2026-02-20) https://www.sec.gov/Archives/edgar/data/1800/000162828026010185/abt-20251231.htm: "Abbott entered into a definitive agreement to acquire Exact Sciences Corporation."
- [confirms] BioSpectator (KO, news, published 2025-11-24) https://www.biospectator.com/news/view/27041: "Abbott said it would acquire Exact Sciences for $105 per share, valuing the deal at $21 billion."

### 빅풋 바이오메디컬 (high)
- note: Abbott acquired Bigfoot Biomedical in 2023 to strengthen connected diabetes-management capabilities. Its 2025 Form 10-K said the purchase price and post-acquisition contribution were not material to the consolidated statements but did not disclose an amount.
- [confirms] SEC EDGAR (EN, filing, published 2026-02-20) https://www.sec.gov/Archives/edgar/data/1800/000162828026010185/abt-20251231.htm: "Abbott completed the acquisition of Bigfoot."
- [mentions] The Henry Fund, University of Iowa (EN, analysis, published 2025-03-14) https://henryfund.tippie.uiowa.edu/sites/henryfund.tippie.uiowa.edu/files/2025-09/s25_ABT.pdf: "Notable acquisitions include Bigfoot Biomedical, a leader in developing smart insulin management systems."

### Illumina (high)  → /illumina.md
- note: Abbott's acquired Exact Sciences business depends on Illumina's sequencing platform for OncoExTra, MRD, and MCED tests and procures related equipment. Equipment and reagent spending is not disclosed.
- [mentions] SEC EDGAR (EN, filing, published 2026-03-23) https://www.sec.gov/Archives/edgar/data/1800/000110465926033079/tm268709d2_8k.htm: "Abbott completed the acquisition of Exact Sciences Corporation."
- [confirms] SEC EDGAR (EN, filing, published 2026-02-13) https://www.sec.gov/Archives/edgar/data/1124140/000112414026000011/exas-20251231.htm: "our OncoExTra test is currently only validated to be performed on Illumina's sequencing platform"

### 아마존 (mid)  → /amazon.md
- note: Abbott's acquired Cancer Diagnostics business uses AWS HealthOmics, S3, EventBridge, and CloudWatch for genomic analysis pipelines. Service spending is not disclosed.
- [confirms] Amazon Web Services (EN, analysis, published 2026-04-17) https://aws.amazon.com/blogs/industries/exact-sciences-transforms-bioinformatics-infrastructure-with-aws-healthomics/: "Exact Sciences selected AWS HealthOmics, a fully managed bioinformatics service."
- [mentions] SEC EDGAR (EN, filing, published 2026-03-23) https://www.sec.gov/Archives/edgar/data/1800/000110465926033079/tm268709d2_8k.htm: "Exact surviving as a direct, wholly owned subsidiary of Abbott."

Reverse side: https://valuechain.wiki/abbott-laboratories/customers.md · Ripple: https://valuechain.wiki/abbott-laboratories/ripple.md

---
Full node: https://valuechain.wiki/abbott-laboratories.md · JSON: https://valuechain.wiki/abbott-laboratories.json